Investors Grab JNCE Even Cheaper Than Its Secondary Stock Offering
March 16, 2021 at 11:21 AM EDT
Looking back to 7 days ago, Jounce Therapeutics Inc (JNCE) priced a 5,000,000 share secondary stock offering at $11.25 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..